Yichao Wan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yichao Wan has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Zilong Tang
Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, PR China
6 shared publicationsHongjuan Chen
Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China
4 shared publicationsChunxing Yan
Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan University of Science and Technology, Xiangtan, Hunan 411201, PR China; Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, PR China
3 shared publicationsJiabing Long
Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, PR China
3 shared publicationsWenyan Wang
Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, China
3 shared publicationsXu Deng
Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, China
3 shared publications
Latest Publications
- Open Access
Synthesis, Antifungal Activity and Molecular Docking Studies of Novel 2-Acyloxybenzamides
A series of 2-acyloxybenzamides were synthesized. The structures of the synthesized compounds were characterized by IR, 1H NMR, 13C NMR, and HRMS. Their antifungal activity against plant pathogenic fungi was evaluated. Compound 3i exhibited a 100.0% inhibition rate against M. oryzae, while compound 3b showed 90.0% inhibition against P. capsici. The corresponding EC50 values of compounds 3b (against P. capsici) and 3i (against M. oryzae) were determined to be 3.90 and 8.21 μg/mL, respectively. Molecular docking and MD simulations studies suggested that SCD enzyme may serve as a potential target for compound 3i and its related analogues.
Open AccessSynthesis, Antifungal Activity and Molecular Docking Studies of Novel 2-Acyloxybenzamides
A series of 2-acyloxybenzamides were synthesized. The structures of the synthesized compounds were characterized by IR, 1H NMR, 13C NMR, and HRMS. Their antifungal activity against plant pathogenic fungi was evaluated. Compound 3i exhibited a 100.0% inhibition rate against M. oryzae, while compound 3b showed 90.0% inhibition against P. capsici. The corresponding EC50 values of compounds 3b (against P. capsici) and 3i (against M. oryzae) were determined to be 3.90 and 8.21 μg/mL, respectively. Molecular docking and MD simulations studies suggested that SCD enzyme may serve as a potential target for compound 3i and its related analogues.
- 21 August 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 299, 118079
Recent advances of small-molecule Mcl-1 inhibitors or degraders as promising anti-cancer agents (2018-present)
- 21 August 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 299, 118079
Recent advances of small-molecule Mcl-1 inhibitors or degraders as promising anti-cancer agents (2018-present)
- 1 September 2024
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 94 (9) , 2438-2444
Synthesis, Biological Evaluation, and Molecular Docking Studies of 7-Azaindole-Acylsulfonamide Derivatives as Mcl-1 Inhibitors
A series of 7-azaindole-acylsulfonamide derivatives was designed, synthesized and evaluated for inhibitory activity against Mcl-1 protein through fluorescence polarization assays (FPAs). Among them, the most potent compounds showed the best inhibitory activities against Mcl-1 with the inhibitory rate of 97% at the concentration of 50 μM, which was a little more potent than the positive control WL-276 (95%).
- 1 September 2024
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 94 (9) , 2438-2444
Synthesis, Biological Evaluation, and Molecular Docking Studies of 7-Azaindole-Acylsulfonamide Derivatives as Mcl-1 Inhibitors
A series of 7-azaindole-acylsulfonamide derivatives was designed, synthesized and evaluated for inhibitory activity against Mcl-1 protein through fluorescence polarization assays (FPAs). Among them, the most potent compounds showed the best inhibitory activities against Mcl-1 with the inhibitory rate of 97% at the concentration of 50 μM, which was a little more potent than the positive control WL-276 (95%).
- 30 July 2024
- Published by Elsevier in Bioorganic Chemistry
- Vol. 151, 107687
Discovery and development of thiazolidine-2,4-dione derivatives as Bcl-2/Mcl-1 dual inhibitors
- 30 July 2024
- Published by Elsevier in Bioorganic Chemistry
- Vol. 151, 107687
Discovery and development of thiazolidine-2,4-dione derivatives as Bcl-2/Mcl-1 dual inhibitors
- 1 December 2023
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 93 (S4) , S928-S933
Synthesis and Anticancer Activity Evaluation of New Quinoline Derivatives
A series of new quinoline derivatives were designed, synthesized and evaluated for antiproliferative activity against two cancer cell lines (MCF-7 and HCCLM-3) and a human normal cell line (HEK293T cells). Among them, 3-(2,7-dimethoxyquinolin-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one displayed the most inhibitory activity against MCF-7 and HCCLM-3 cells, which were equal and better than the positive control 5-fluorouracil (82.18% vs. 83.29%, 94.79% vs. 76.98%), respectively. Additionally, it had poor inhibitory activity (48.14%) against HEK293T cells, which displayed good selectivity for cancer cells. Therefore, 3-(2,7-dimethoxyquinolin-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one could be as a lead compound to develop more potent anticancer agents.
- 1 December 2023
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 93 (S4) , S928-S933
Synthesis and Anticancer Activity Evaluation of New Quinoline Derivatives
A series of new quinoline derivatives were designed, synthesized and evaluated for antiproliferative activity against two cancer cell lines (MCF-7 and HCCLM-3) and a human normal cell line (HEK293T cells). Among them, 3-(2,7-dimethoxyquinolin-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one displayed the most inhibitory activity against MCF-7 and HCCLM-3 cells, which were equal and better than the positive control 5-fluorouracil (82.18% vs. 83.29%, 94.79% vs. 76.98%), respectively. Additionally, it had poor inhibitory activity (48.14%) against HEK293T cells, which displayed good selectivity for cancer cells. Therefore, 3-(2,7-dimethoxyquinolin-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one could be as a lead compound to develop more potent anticancer agents.
- 1 July 2023
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 258, 115621
Azaindole derivatives as potential kinase inhibitors and their SARs elucidation
- 1 July 2023
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 258, 115621
Azaindole derivatives as potential kinase inhibitors and their SARs elucidation
- 1 June 2022
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 92 (6) , 1109-1114
Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Indazole Derivatives as Bcl-2/Mcl-1 Dual Inhibitors
In this study, a series of new indazole derivatives has been designed, synthesized and evaluated for inhibitory activity against anti-apoptotic Bcl-2 proteins (Bcl-2, Mcl-1, Bcl-xL). Among them, three products have demonstrated high inhibitory activity against Bcl-2/Mcl-1, which is similar to that of the positive control compound WL-276. Their poor Bcl-xL inhibitory activity allows to avoid platelet toxicity caused by Bcl-xL inhibition. Hence, they might be considered as lead compounds for developing Bcl-2/Mcl-1 dual inhibitors of higher potency.
- 1 June 2022
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 92 (6) , 1109-1114
Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Indazole Derivatives as Bcl-2/Mcl-1 Dual Inhibitors
In this study, a series of new indazole derivatives has been designed, synthesized and evaluated for inhibitory activity against anti-apoptotic Bcl-2 proteins (Bcl-2, Mcl-1, Bcl-xL). Among them, three products have demonstrated high inhibitory activity against Bcl-2/Mcl-1, which is similar to that of the positive control compound WL-276. Their poor Bcl-xL inhibitory activity allows to avoid platelet toxicity caused by Bcl-xL inhibition. Hence, they might be considered as lead compounds for developing Bcl-2/Mcl-1 dual inhibitors of higher potency.
- 1 March 2022
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 92 (3) , 464-469
Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Thiazolidine-2,4-dione Derivatives as Mcl-1 Inhibitors
In the study, two series of thiazolidine-2,4-dione derivatives have been designed, synthesized and evaluated for their inhibitory activity of Mcl-1 protein by fluorescence polarization assays (FPAs). Among those, the most potent product has demonstrated inhibitory activity against Mcl-1 (inhibitory rate 94% at 10 μM) higher than that of the positive control WL-276 (90%).
- 1 March 2022
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 92 (3) , 464-469
Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Thiazolidine-2,4-dione Derivatives as Mcl-1 Inhibitors
In the study, two series of thiazolidine-2,4-dione derivatives have been designed, synthesized and evaluated for their inhibitory activity of Mcl-1 protein by fluorescence polarization assays (FPAs). Among those, the most potent product has demonstrated inhibitory activity against Mcl-1 (inhibitory rate 94% at 10 μM) higher than that of the positive control WL-276 (90%).
- Top Cited Papers
- 1 December 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 226, 113837
Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation
- 1 December 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 226, 113837
Top Cited PapersSulfonamide derivatives as potential anti-cancer agents and their SARs elucidation
- 1 June 2021
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 91 (6) , 1112-1116
Synthesis and Anti-Fungal Activity of New 3-Aryl-1,3-benzoxazine-2-ketone Derivatives
In the study, a series of new 3-aryl-1,3-benzoxazine-2-ketone derivatives has been designed, synthesized and evaluated for anti-fungal activity against six species of phytopathogenic fungi. Among those, two compounds have exhibited high inhibitory activity against M. oryzae at the concentration of 50 μg/mL, being more potent than the positive control chlorothalonil.
- 1 June 2021
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 91 (6) , 1112-1116
Synthesis and Anti-Fungal Activity of New 3-Aryl-1,3-benzoxazine-2-ketone Derivatives
In the study, a series of new 3-aryl-1,3-benzoxazine-2-ketone derivatives has been designed, synthesized and evaluated for anti-fungal activity against six species of phytopathogenic fungi. Among those, two compounds have exhibited high inhibitory activity against M. oryzae at the concentration of 50 μg/mL, being more potent than the positive control chlorothalonil.